Trials / Unknown
UnknownNCT04493073
Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy
Comparison of Conjunctival Vascularity Changes Using Optical Coherence Tomography Angiography After Trabeculectomy With Mitomycin and Ologen Implants
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Asmaa Ahmed Ali Youssif · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
* Reduce the trauma and the time taken for patient rehabilitation. * The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication. * Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.
Detailed description
The main purpose of this project is to compare bleb vascularity changes using optical coherence tomography (OCT-A) between mitomycin- C (MMC)-augmented trabeculectomy and develop trabeculectomy with ologen implants to determine whether bleb vascularity measurements during preoperative and early postoperative periode could act as surrogate parameters to predict surgical outcomes. Glaucoma often existent in the elderly population. Measuremets of bleb vascularity beginning to become an essential part of the glaucoma specialist's clinical and operative took. As investigators continue to collect data both clinically and in the laboratory, these various imaging modalities will shepherd surgeons into a more precise and predicable era of glaucoma surgeries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Trabectulectomy | decrease IOP |
| DRUG | Mitomycin | Decrease bleb failure |
| DEVICE | Ologen Collagen Implant | Ologen Collagen Implant (Aeon Astron Europe, Netherlands) |
| DEVICE | Mitomycin-C Kyowa® | Mitomycin-C Kyowa® (Biochem Pharmaceutical Industries, India) |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-12-01
- Completion
- 2022-03-01
- First posted
- 2020-07-30
- Last updated
- 2020-07-30
Source: ClinicalTrials.gov record NCT04493073. Inclusion in this directory is not an endorsement.